Company intelligence / Profile preview

Texas Liver Institute

San Antonio, Texas, United States

Ownership: Private
Development stage: Other

Overview

Texas Liver Institute is internationally recognized for clinical research and care in liver diseases, including leading and participating in Phase 2 and 3 clinical trials for novel therapeutics in hepatitis, fatty liver disease, autoimmune conditions, and cirrhosis. Results and access to investigational therapies are regularly provided to patients, but TLI does not develop drugs in-house; rather, it serves as a key investigator site for external biotech and pharma sponsors.

Therapeutic areas: GastroenterologyInfectious DiseasesImmunology
Industry: Academic Hospital/University/Research

Partnerships

University of Texas Health Science Center at San Antonio

Beyond the preview

Go deeper on Texas Liver Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Texas Liver Institute.

Explore the full profile